ARCFAmerican Respiratory Care Foundation
TrusteesAwardsAward Recipients ConferencesInternationalSupportNewsContact Us

Mitchell A. Baran Achievement Award for Clinical Excellence in Aerosol and Airway Clearance Therapies

This annual achievement award was established in 2016 to honor the memory and legacy of Mitchell A. Baran, founder and Chairman of the Trudell Medical Group, a global manufacturer of medical devices. Monaghan Medical Corporation, the subsidiary of Trudell Medical, is a leading innovator in the evidence-based delivery of aerosolized medications and airway clearance therapies.


Throughout his long and distinguished career, Mr. Baran was unwavering in his commitment to the necessity of basing product development and subsequent application on a foundation of established scientific evidence, coupled with the clinical expertise of those using such devices.

An endowment has been established in the American Respiratory Care Foundation (ARCF) to recognize and honor those individuals demonstrating clinical excellence and leadership in advocating and promoting the use of evidence-based, clinically sound practices for the delivery of aerosolized medications and/or the application of non-pharmacologic airway clearance therapies.


Recipients of this award will receive a cash prize of $2,500, a piece of engraved crystal and round-trip coach airfare, with two nights lodging and registration, to the Annual AARC Congress for the year in which the award is bestowed.


Eligibility and Nominating Procedure:

At the beginning of each calendar year, the ARCF will invite nominations for the Mitchell A. Baran award from the AARC's Board of Medical Advisors (BOMA), the Board of Directors of the American Association for Respiratory Care, the Trustees of the American Respiratory Care Foundation, and the National Board for Respiratory Care. The ARCF Board of Trustees in consultation with the Board of Medical Advisors Chair will make the final selection for the award recipient. Eligible candidates will, at minimum, possess the registered respiratory therapist (RRT) credential and be an active member of the AARC for at least seven years. It is anticipated that nominees will also have a record of voluntary service to the AARC and/or related professional organizations, with special emphasis given to those individuals exhibiting demonstrable clinical leadership skills.

A completed nomination must include the following:

  • A description of the nominee's professional background (i.e. a current curriculum vitae)
  • A detailed narrative describing the nominee's achievements in advocating and promoting excellence in the delivery of aerosolized mediations, airway clearance therapy and the impact such activities have had on patients, their families, and other clinicians, and
  • A brief notation on clinical research activities undertaken to further and strengthen the knowledge base of aerosol medicine and non-pharmacologic airway clearance therapy.

Completed nominations must be received by the ARCF Executive Office no later than June 1 of the calendar year in which the award is to be bestowed.

Upon selection, the nominee will be so notified and invited to attend the Award Ceremony, held in conjunction with the AARC's Annual Congress. The recipient of the award will also be invited to attend the annual BOMA Reception for further recognition and accolades.

Past Award Recipients


Back to Achievement Awards

© 2018 American Respiratory Care Foundation